Stay updated on Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.

Latest updates to the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA new page revision tag 'Revision: v3.6.4' appears, replacing the previous 'Revision: v3.6.3'. This reflects an updated page build or patch without altering the study content.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedRevision: v3.6.3 was added, replacing the previous v3.6.2. This reflects a minor page update that does not alter study details or functionality.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision: v3.6.2 is now shown on the page, replacing the previous Revision: v3.6.0. This reflects a minor update to the page’s release version without altering the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedThe study page now states it is no longer recruiting participants and adds sections on reading the study record, common questions, and how to join. Formatting for the Intervention/Treatment heading was adjusted and the revision note updated to v3.6.0.SummaryDifference0.3%

- Check59 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, indicating a new revision was recorded.SummaryDifference0.0%

- Check80 days agoChange DetectedThe page's revision line was updated from Revision: v3.5.3 to Revision: v3.5.4, indicating an administrative update to the page metadata.SummaryDifference0.0%

Stay in the know with updates to Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir vs Lopinavir/Ritonavir in Second-line Clinical Trial page.